Abstract Permeability-limited two-subcompartment and flow-limited, well-stirred tank tissue compartment models are routinely used in physiologically-based pharmacokinetic modeling. Here, the permeability-limited two-subcompartment model is used to derive a general flow-limited case of a two-subcompartment model with the well-stirred tank being a specific case where tissue fractional blood volume approaches zero. The general flow-limited two-subcompartment model provides a clear distinction between two partition coefficients typically used in PBPK: a biophysical partition coefficient and a well-stirred partition coefficient. Case studies using diazepam and cotinine demonstrate that, when the well-stirred tank is used with a priori predicted biophysical partition coefficients, simulations overestimate or underestimate total organ drug concentration relative to flow-limited two-subcompartment model behavior in tissues with higher fractional blood volumes. However, whole-body simulations show predicted drug concentrations in plasma and lower fractional blood volume tissues are relatively unaffected. These findings point to the importance of accurately determining tissue fractional blood volume for flow-limited PBPK modeling. Simulations using biophysical and well-stirred partition coefficients optimized with flow-limited two-subcompartment and well-stirred models, respectively, lead to nearly identical fits to tissue drug distribution data. Therefore, results of whole-body PBPK modeling with diazepam and cotinine indicate both flow-limited models are appropriate PBPK tissue models as long as the correct partition coefficient is used: the biophysical partition coefficient is for use with two-subcompartment models and the well-stirred partition coefficient is for use with the well-stirred tank model.
Introduction
Physiologically-based pharmacokinetic modeling has seen widespread use in toxicology and is emerging as an important tool in drug development [1] . The basic element of PBPK modeling is the tissue compartment model, and for over 30 years, the permeability-limited two-subcompartment model and its flow-limited counterpart, the wellstirred tank, have defined the field of PBPK. The permeability-limited two-subcompartment model has a sound mechanistic basis, as it can be derived [2] from the 1D advection equation [3] assuming a lumped or spatially homogenized treatment of the vascular region. Therefore, in making comparisons of the different tissue compartment models, the permeability-limited two-subcompartment model is assumed to be the most biophysically realistic model that is required to simulate ADME processes operating on slower timescales. In the recent work of Thompson and Beard [2] , the development of permeability-limited two-region asymptotically reduced and flow-limited tworegion asymptotically reduced tissue compartment models afforded the opportunity to reevaluate the permeabilitylimited two-subcompartment and well-stirred tank models.
Herein, this work is further extended by considering the permeability-limited two-subcompartment model in the limit of higher permeation relative to flow. A flow-limited two-subcompartment model is proposed that distinguishes two types of partition coefficients used in PBPK which are evaluated using pharmacokinetic data from the rat.
Methods: theoretical
Case I (definition): biophysical partition coefficient Physicochemical properties of drugs are used to predict and/or constrain PBPK model parameters such as the partition coefficient [4, 5] . The biophysical partitioning of a drug between the blood and tissues is determined in part by the thermodynamically-driven transfer of drug molecules between lipid and water phases [6] . To simplify and implement this biophysical partitioning in a PBPK tissue model, partitioning between the blood and tissue can be minimally represented by a two-compartment, well-mixed system at equilibrium. Therefore, the biophysical partition coefficient is defined from this equilibrium partitioning as
where c tissue is the concentration of drug in the tissue and c plasma is the concentration of drug in the plasma. This definition is most appropriately applied to a two-subcompartment, vascular:extravascular model where c tissue is the extravascular space, denoted by c 2 in the model below, and where c plasma is the vascular space, denoted by c 1 in the model. Advantageously, the biophysical partition coefficient is amenable to experimental measurement with techniques such as vial-equilibration methods [7] using tissue homogenates to determine partition coefficients for PBPK modeling [8] . In addition, algorithms have been developed based on drug physicochemical properties and tissue composition to generate a priori predicted partition coefficients for PBPK modeling applications [4, 5, 9] . Since the term tissue:plasma partition coefficient (P t:p ) is used by Poulin et al. [4] when discussing a priori predicted values, the biophysical partition coefficient used herein is denoted as k biophys and is meant to imply a predicted value for P t:p , an in vitro measurement, or a value arrived at through fitting data with a two-subcompartment model. Case I (model): two-subcompartment PBPK tissue model for use with the biophysical partition coefficient (k biophys )
The biophysical partition coefficient used in PBPK modeling is most appropriately applied to the permeabilitylimited two-subcompartment model referred to as PLT by Thompson and Beard [2] . The permeability-limited two-subcompartment model is given by
and
where Q is flow, c in is the inflow concentration of drug, c 1 is the concentration of drug in the vascular subcompartment, V 1 is the vascular volume, c 2 is the concentration of drug in the extravascular subcompartment, V 2 is the extravascular volume, PS is the permeability-surface area product of the drug, and k biophys is the partition coefficient of the drug relating c 2 to c 1 from Eq. 1.
Case II (definition): well-stirred partition coefficient
In 1984 [10] , Rowland concisely discussed the issues of defining a steady-state partition coefficient for use in whole-body PBPK modeling and summarized the argument for the venous equilibrium partition coefficient as
where c T is the average concentration of drug in a single compartment model and the outflowing venous blood, c out , is at equilibrium with c T . Herein, this steady-state, wellstirred partition coefficient will be denoted as k well-stirred .
Case II (model): single compartment well-stirred tank PBPK tissue model for use with the well-stirred partition coefficient (k well-stirred )
The single compartment well-stirred tank is the default flow-limited tissue model used in PBPK applications unless physicochemical properties or pharmacokinetic time courses for tissue distribution indicate a possible permeability limitation [2] . The well-stirred tank (WST) model is governed by
where Q is flow, c in is the inflow concentration of drug into the single compartment, c T is the average or overall concentration of the well-stirred compartment, V T is the total volume of the compartment, and k well-stirred is the partition coefficient of drug at steady-state relating c T to c out from Eq. 4.
Use of well-stirred and biophysical partition coefficients
The biophysical and well-stirred partition coefficients are defined to varying degrees in the literature [11] [12] [13] , and the relationship between them is often unclear [5] . Failing to clearly distinguish well-stirred and biophysical partition coefficients leads to instances where the two definitions are used interchangeably between permeability-limited and flow-limited models [14, 15] , even though they imply and express different mathematical relationships between tissue and blood concentrations of drug based on the use of a two-subcompartment versus a single compartment tissue model.
Methods: flow-limited two-region model development
Recently, a PBPK tissue compartment modeling approach was developed by Thompson and Beard [2] that began to highlight this distinction. Using a singular perturbation analysis of the permeability-limited model (PLT), a new two-region asymptotically reduced model was developed that uses only one state variable. The permeability-limited two-region asymptotically reduced (P-TAR) model is given by
and c 1 is subsequently computed as
In the flow-limiting case (PS=Q ! 1), Eqs. 6 and 7 reduce to
giving the flow-limited two-region asymptotically reduced (F-TAR) model. To conserve mass, the outflow concentration, c out , is computed using the dynamic mass balance equation
to give c out for the permeability-limited two-region asymptotically reduced case as
and c out for the F-TAR case as
Further conditional statements are discussed and applied in Thompson and Beard [2] . Equations 6 through 12 allow drug concentration to be simulated in both vascular and extravascular regions by solving only one differential equation for either case.
To evaluate the permeability-limited two-region asymptotically reduced model and the F-TAR model, comparisons were made to the standard permeability-limited two-subcompartment (PLT) (Eqs. 2, 3) and well-stirred tank (WST) (Eq. 5) models. As shown in Thompson and Beard [2] , the P-TAR and F-TAR tissue models closely approximate the behavior of the permeability-limited twosubcompartment model and the permeability-limited twosubcompartment model in the limit of PS=Q ! 1, respectively. However, from this analysis, the well-stirred tank model appeared to not be an appropriate choice when drugs differentially partition between the blood and tissue spaces [2] . Further theoretical analysis of 75 drugs with a range of a priori predicted partition coefficients evaluated in a set of eight rat tissues and organs showed that use of the well-stirred tank model to simulate flow-limited transport in whole-body PBPK modeling can potentially result in large differences in model simulations compared to the F-TAR model [16] .
As a result of these studies, herein we develop a model to simulate the flow-limited extreme of the permeabilitylimited two-subcompartment model that is as accurate as and somewhat more convenient than the asymptotic approximation of the F-TAR model. The flow-limited twosubcompartment model formulation, which provides a clear theoretical framework to implement the biophysical partition coefficient and distinguish it from the well-stirred partition coefficient, is described and evaluated below.
Methods: flow-limited two-subcompartment model development
Consider the total concentration of solute in a two-subcompartment system:
where c 1 and c 2 are the concentrations of solute in the subcompartments, V 1 and V 2 are the volumes of the subcompartments, and V T = V 1 ? V 2 . Taking the time derivative,
and substituting Eqs. 2 and 3, the governing equation for total concentration is
Assuming rapid equilibration between the vascular and extravascular spaces (c 2 = k biophys c 1 ), the outflow concentration (c 1 ) is given by
where FBV = V 1 /V T is the fractional blood volume (FBV) of the compartment. Substituting into Eq. 15, we have
The flow-limited two-subcompartment model (Eq. 17) can be re-expressed with
to simulate the same time courses as the well-stirred tank (Eq. 5). Figure 1a diagrams the flow-limited two-subcompartment model with rapid mixing and equilibration between the vascular and extravascular spaces. The well-stirred tank is obtained from the flow-limited two-subcompartment model in the limit of V 1 =V T ! 0 (Fig. 1b) where the FBV approaches zero and the outflow concentration of the flowlimited two-subcompartment model approaches the outflow concentration of the well-stirred tank model. Therefore, the well-stirred tank model is a specific flow-limited case of the permeability-limited two-subcompartment model. In summary, we propose the following: (1) the flowlimited two-subcompartment model of Eq. 17 is the appropriate flow-limited counterpart to the permeability-limited two-subcompartment model for use in PBPK modeling when using the biophysical definition of the partition coefficient (k biophys ); (2) the well-stirred tank is an appropriate PBPK tissue model when using the well-stirred definition for the partition coefficient (k well-stirred ); and (3) the two partition coefficients, k biophys and k well-stirred , are related by a tissue's FBV, assuming drug transport is flow-limited in a tissue with rapid equilibration between subcompartments.
Methods: PBPK tissue compartment model analysis
To demonstrate the effect of using a biophysical partition coefficient with the well-stirred tank, an open loop circulatory model [16] is used to simulate inflow concentration with
where k a (= 0.001 s -1 ) is the absorption rate constant, k el (= 0.0005 s -1 ) is the elimination rate constant, and c dose is set to 2 arbitrary units (a.u.) of concentration. A worst-case scenario is assessed using a model representing the human kidney. Physiological parameter values are from Brown, et al. [17] . The human kidney receives a mean flow distribution of cardiac output equal to 17.5 %, or 1,138 ml min -1 for a cardiac output of 6.5 l min -1 . For a 70 kg person, the kidney weight is 308 g (0.44 % of the body weight) or 293 ml (kidney density of 1.05 g ml -1 ). The FBV for the human kidney has been reported to be up to 50 % [17] with a mean value of 36 %. Simulations (Fig. 2 ) use a value of 50 % for kidney FBV. Drug-specific parameters are k biophys = 0.25 and 25, with the low and high values selected based on the range of k biophys in eight rat tissues and organs from a previous analysis of a priori predicted P t:p for 75 structurally-unrelated drugs [16] . The k well-stirred value is calculated based on Eq. 18. Both C max and area under the curve (AUC) are assessed with the percent difference of the well-stirred model (using k biophys ) expressed relative to the flow-limited two-subcompartment model (using the same k biophys ).
Though this set of simulations shows how model agreement depends on the partition coefficient definition used, evaluation of rat pharmacokinetic data for two drugs, diazepam and cotinine, provides an opportunity to study PBPK tissue model behavior in a whole-body context.
Methods: case study of diazepam (k > 1) in the rat
Diazepam is a well-studied benzodiazepine with several tissue distribution studies in the literature [18] [19] [20] [21] forming the basis of diazepam PBPK modeling papers on optimization [18, 22] , fuzzy simulation [19, 23] , and Bayesian approaches [20] . The PBPK model structure (Fig. 3) proposed for diazepam analysis [20] is used herein to evaluate the new flow-limited two-subcompartment model (using k biophys ) compared to the well-stirred tank (using k biophys and k well-stirred ). The physicochemical properties of diazepam (logP value of 2.99 [5] and an unbound fraction (fu) in the plasma of 0.15 [19] ), result in predicted partition coefficients [1 for all tissues (Table 2 ) based on the method of Poulin, et al. [4, 5] with the correction by Berezhkovskiy [24] . The ratio of blood to plasma diazepam is set equal to 1 [18] . Tissue time course data for diazepam in the rat (1 mg kg -1 , intravenous infusion) are from the work of Gueorguieva et al. [20] . Rat tissue blood flows and tissue masses are obtained from Gueorguieva, et al. [20] and can be found in Table 1 . FBV is obtained from the work of Everett, et al. [25] or Brown, et al. [17] , with values given for both the mean and range of FBV when available, as indicated in Table 1 . Values for the human [17] are also provided in Table 1 for reference. The well-stirred tank model equations governing liver metabolism of diazepam are based on Gueorguieva et al. [20] . Herein, the equations for the well-stirred model are presented as
where R is the blood to plasma ratio, fu is the unbound fraction in plasma, fu b = fu/R, and CL INT is the intrinsic ; physiological parameters:
; drug-specific parameter: a k biophys = 0.25 with k well-stirred calculated based on Eq. 18; b k biophys = 25 with k well-stirred calculated based on Eq. 
with Eq. 23 reducing to Eq. 22 when FBV approaches zero or k biophys = 1.
Methods: case study of cotinine (k < 1) in the rat
Cotinine is a polar metabolite of nicotine that has been used as a biomarker for smoking exposure [26] with previous PBPK modeling indicating cotinine has flow-limited distribution to tissues in the rat [27] . Cotinine is predicted to have partition coefficients less than 1 for all tissues (Table 4 ) based on the method of Poulin, et al. [4] with the correction by Berezhkovskiy [24] . The ratio of blood to plasma cotinine is equal to 0.88 [28] . Physicochemical properties of cotinine include a logP value of -0.3 [29] and an fu in the plasma of 0.97 [4] . Tissue time course data for cotinine (0.5 mg, intravenous bolus) in the rat are obtained from the published work of Gabrielsson, et al. [27] , digitized (ScanIt V1.04, AmsterCHEM, Almeria, Spain), and analyzed with the same model structure used for diazepam (Fig. 3) . Based on the tissues reported [27] , the level of detail in the PBPK model structure is preserved without lumping; however, the values for partition coefficients used for the skin, stomach, and testes are assumed to be the same as the remainder compartment, both during optimization as well as simulation with a priori predicted values (Table 4) .
All simulations and optimization using Monte Carlo and fmincon approaches are carried out in Matlab v.R2010a, (Mathworks, Natick, MA).
Results and discussion
Comparing models using biophysical and well-stirred partition coefficients As shown previously [2] , the permeability-limited tworegion asymptotically reduced model closely follows permeability-limited two-subcompartment model behavior and the F-TAR model closely follows a numericallyapproximated (PS=Q ! 1), flow-limited version of the permeability-limited two-subcompartment model. Neither [19] . Cotinine simulations use the same model structure 
The hierarchy of tissue models (the permeability-limited two-subcompartment leading to the flowlimited two-subcompartment leading to the well-stirred tank) demonstrates that all of the tissue models are biophysically appropriate; however, the models differ regarding the interpretation of the partition coefficient. Simulations show that the flow-limited two-subcompartment model agrees well with the numerically-approximated, flow-limited version of the permeability-limited Fig. 4 Simulated concentration-time curves using a priori predicted partition coefficients for diazepam. Plasma, adipose, brain, heart, kidney, liver, lung, muscle, skin, splanchnic, stomach, and testes concentration-time curves are simulated using a priori predicted partition coefficients based on the method of Poulin et al. [4] with the correction by Berezhkovskiy [24] . Well-stirred tank (solid black lines) and flow-limited two-subcompartment (dashed gray lines) model simulations are plotted against pharmacokinetic data (open circles) in the rat from Gueorguieva et al. [20] . Diazepam partition coefficient values are reported in Table 2 , and AUC values are reported in Table 3 two-subcompartment model, as well as the F-TAR model regardless of the value of the k biophys partition coefficient. However, when the same partition coefficient, k biophys , is used in the well-stirred tank model, the well-stirred tank overestimates c T (Fig. 2b , solid black line indicated by black arrowhead) when k biophys is[1 and underestimates c T (Fig. 2a , solid black line indicated by black arrowhead) when k biophys is \1. The worst-case result of not correcting a priori predicted partition coefficients prior to use in the well-stirred tank model is explored with an open circulatory loop approach, here using physiological parameters for the human kidney. Both the peak concentration (C max ) and AUC substantially differ between well-stirred tank and flow-limited two-subcompartment model simulations. Well-stirred tank C max percent difference ranges from -60 to ?86 % and well-stirred tank AUC percent difference ranges from -60 to ?103 % (when k biophys is set to 0.25 and 25, respectively). If the k biophys value used with the well-stirred tank is adjusted according to Eq. 18, the wellstirred simulations ( Fig. 2a, b ; solid light gray lines) match flow-limited two-subcompartment simulations ( Fig. 2a, b ; dashed black lines).
Tissues and organs, such as the skin, brain, adipose, and skeletal muscle have relatively small FBVs and the differences will be substantially less [16] . However, spleen, heart, lung, and tissues and organs that play key roles in ADME processes, such as liver and kidney, have higher FBVs [17] . Thus theoretically, proper matching of a flow-limited model with a partition coefficient is important. However, whole-body analysis of pharmacokinetic data is needed to evaluate these theoretical considerations.
Diazepam case study: pharmacokinetics in the rat
Simulations using a priori predicted partition coefficients for diazepam Since the well-stirred tank is a reasonable approximation of the flow-limited two-subcompartment model when tissue FBV is low (adipose, brain, muscle, skin, splanchnic, stomach, and testes), well-stirred simulations ( Fig. 4 ; solid black lines) are very close to flow-limited two-subcompartment simulations ( Fig. 4; dashed gray  lines) . AUC values are listed by tissue in Table 3 . The percent difference for these tissues averages -2.7 % (range of -1.9 to -3.6 %). Simulations of plasma concentration of diazepam also show well-stirred tank simulations ( Fig. 4 ; solid black lines) being nearly identical to flow-limited two-subcompartment simulations (Fig. 4 ; dashed gray lines). This observation implies that selection of an inappropriate partition coefficient for use with the well-stirred tank PBPK tissue model has minimal impact on the systemic kinetics of plasma diazepam (Table 3,  AUC) . This finding may be partly explained by the PBPK model structure used herein, where approximately 87 % of tissue mass has a FBV of B0.05. Counter to findings in low FBV tissues and the plasma, tissues and organs with higher FBVs, plotted in Fig. 4 (heart, kidney, liver, lung) , do differ more when a priori values are used with both models. AUC values (Table 3 ) for these organs differ by an average of -21.3 % (range of -12.5 to -35.7 %). Also, in the tissues with higher FBV, the flow-limited two-subcompartment model simulations using a priori predicted partition coefficients are closer to the experimental data, indicating that consideration of FBV by the flow-limited two-compartment model may improve model prediction for diazepam. b k apriori is the a priori predicted tissue:plasma partition coefficients for diazepam estimated using the method of Poulin et al. [4] with the correction by Berezhkovskiy [24] ; k biophys is the biophysical partition coefficient between the two subcompartments; k well-stirred is the wellstirred partition coefficient of the single compartment well-stirred tank; the partition coefficients, k biophys and k well-stirred , are determined via optimization c Stomach and testes compartments are given the same k apriori partition coefficient values as the remainder (k apriori,avg = 4.9) d Predicted intrinsic clearance from Poulin, et al. [5] e Optimized intrinsic clearance value corresponding to each given set of optimized partition coefficients Optimization of diazepam partition coefficients and clearance parameters with well-stirred tank and flow-limited two-subcompartment models Partition coefficients optimized using the well-stirred tank model differ from coefficients optimized using the flowlimited two-subcompartment model in a predictable manner (Table 2 ). Higher FBV organs (heart, 20.4 %; lung, 27.4 %) differ the most in optimized partition coefficient values. Simulations using the optimized values ( Fig. 5 ; well-stirred simulation, solid black line; flow-limited two-subcompartment, dashed gray line) and AUC data (Table 3) show the models produce similar results, including simulation of diazepam plasma concentration. Therefore, for drugs with partition coefficients greater than 1, optimization with either the flow-limited Fig. 5 Simulated concentration-time curves using well-stirred and flow-limited two-subcompartment model-optimized partition coefficients for diazepam. Lower FBV tissues (adipose, brain, muscle, skin, splanchnic, stomach, and testes), higher FBV tissues (heart, kidney, liver, lung), and plasma concentration-time curves are simulated using optimized partition coefficients. The well-stirred model is used to optimize diazepam well-stirred partition coefficients, and the flowlimited two-subcompartment model is used to optimize diazepam biophysical partition coefficients (Table 2) . Well-stirred tank (solid black lines) and flow-limited two-subcompartment (dashed gray lines) model simulations are plotted against pharmacokinetic data (open circles) in the rat from Gueorguieva et al. [20] . AUC values are reported in Table 3 J Pharmacokinet Pharmacodyn (2012) 39:313-327 321 two-subcompartment model (using k biophys ) or with the well-stirred tank (using k well-stirred ) produce similar fits to experimental data.
Cotinine case study: pharmacokinetics in the rat
Simulations using a priori predicted partition coefficients for cotinine Similar to findings for diazepam, well-stirred tank simulations ( Fig. 6 ; solid medium gray lines) are very close to flow-limited two-subcompartment simulations ( Fig. 6 ; dashed dark gray lines) for low FBV tissues. However, simulations for tissues with higher FBVs are also similar because the a priori predicted coefficients are relatively close to 1 (Table 4 , cotinine partition coefficients). The AUC percent difference for tissues averages 3.4 % (range of 0.9-7.3 %). Simulations of plasma concentration of cotinine are even closer (0.5 %, Table 5 ), again showing that use of a biophysical partition coefficient in the wellstirred tank model has minimal impact on the systemic kinetics of plasma cotinine. However, fits of a priori based simulations to the experimental data are poor, as a priori prediction overestimated the values for the tissue partition coefficients. This leads to larger uptake by tissues and lower plasma concentrations than observed in the rat pharmacokinetic study. As seen in Table 4 , the difference between a priori values and either biophysical or wellstirred coefficients is greater than the difference between the biophysical and well-stirred partition coefficients. As a result, a priori predicted values for cotinine do not provide a reference point to which flow-limited two-subcompartment optimized partition coefficients can readily be compared. This result is not entirely unexpected as Rodgers, et al. noted that methods to predict partition coefficients are considered reasonably accurate if within a factor of 3 of the experimentally determined values [30] .
Optimization of cotinine well-stirred partition coefficients using the well-stirred tank model and translation of well-stirred partition coefficients to biophysical partition coefficients
In contrast to the case study of diazepam, only the wellstirred partition coefficients are optimized for cotinine. The optimized well-stirred partition coefficients are then adjusted based on Eq. 18 to give the biophysical partition coefficients for the flow-limited two subcompartment model simulations, with the clearance parameter kept the same between the models (Table 4) . In this situation, wellstirred simulations ( Fig. 7 ; solid light gray lines) are nearly identical to flow-limited two-subcompartment simulations ( Fig. 7 ; dashed dark gray lines) in all tissues (Table 5 , AUC percent difference) with one exception. The optimized well-stirred partition coefficient for cotinine in the lung is lower than the FBV for the lung. The relationship between k well-stirred and k biophys , as described by Eq. 18, yields a value for k biophys that would be negative. Since a negative concentration ratio is not reasonable in PBPK, an arbitrarily low value for k biophys is used in the simulation. As seen in Fig. 7 , the flow-limited two-subcompartment model (dashed dark gray line) cannot fit the lung data, unlike the well-stirred tank (solid light gray line). This finding implies either: (1) the FBV of the lung in the Gabrielsson, et al. [27] study was less than the reported value of Brown, et al. [17] and less than the well-stirred partition coefficient for cotinine in the lung; or (2) cotinine distribution to the lung is actually not flow-limited but rather permeability-limited. In this latter case, the optimized parameter for the lung is clearly only meaningful if the appropriate tissue model structure is used. If a permeability-limitation exists, but a flow-limited model is used to fit pharmacokinetic data, the meaningfulness of the model parameters is questionable. The lung cotinine example demonstrates the potential benefit to using the flow-limited two-subcompartment model along with the well-stirred tank to better understand drug pharmacokinetics through incorporation of more biophysical and physiological detail into PBPK tissue models. Simulated concentration-time curves using a priori predicted partition coefficients for cotinine. Adipose, brain, heart, kidney, liver, lung, muscle, and splanchnic concentration-time curves are simulated using a priori predicted partition coefficients based on the method of Poulin et al. [4] with the correction by Berezhkovskiy [24] . Well-stirred tank (solid medium gray lines) and flow-limited two-subcompartment (dashed dark gray lines) model simulations are plotted against rat pharmacokinetic data from Gabrielsson, et al. [27] (filled dark gray circles, mean; vertical bars, range). Plasma concentration-time curves are also plotted in each tissue panel (well-stirred, solid light gray lines; flow-limited two-subcompartment, dashed medium gray lines) against rat plasma time course data (filled light gray squares, mean; vertical bars, range). Partition coefficient values for cotinine are reported in Table 4 , and AUC values are reported in Table 5 J Pharmacokinet Pharmacodyn (2012) 39:313-327 323 Table 1 b k apriori is the a priori predicted tissue:plasma partition coefficient for cotinine estimated using the method of Poulin et al. [4] with the correction by Berezhkovskiy [24] ; k biophys is the biophysical partition coefficient between the two subcompartments; k well-stirred is the well-stirred partition coefficient of the single compartment well-stirred tank c The k biophys partition coefficients are calculated from optimized k well-stirred values using Eq. 18 with the partition coefficient for lung being set arbitrarily low (indicated by *) d The k well-stirred partition coefficients are determined via optimization e Skin, stomach, and testes were kept as compartments in the model but were given the same respective partition coefficient value as the remainder (k apriori,avg = 0.78, k biophys = 0.14, or k well-stirred = 0.18) f Well-stirred tank-optimized intrinsic clearance value is used in flow-limited two-subcompartment simulations g Well-stirred tank-optimized intrinsic clearance value Implication for physiological measurements
The relationship between the biophysical and well-stirred partition coefficients is summarized in Fig. 8 . The ratio of k well-stirred to k biophys varies between 1 and 1-FBV when k biophys [ 1, and the percent difference of k biophys versus k well-stirred varies between 0 and 100*FBV when k biophys [ 1. For a drug with a biophysical partition coefficient of [1 in the rat lung, where mean FBV is 0.36 [16] , the lowest possible ratio of k well-stirred to k biophys is 0.64 and the largest percent difference is 36 %. As an example, for diazepam in the rat lung (Table 2 , FLT-optimized and WST-optimized partition coefficients), the ratio is 0.73 and the percent difference is 27.4 %. However, if the drug partition coefficient is \1, the ratio of k well-stirred to k biophys and the absolute percent difference can become very large.
Since the biophysical and well-stirred partition coefficients are related to each other by tissue FBV, FBV takes on newfound importance as a fixed parameter in flowlimited PBPK tissue models, whereby previous use of FBV was largely restricted to permeability-limited two-subcompartment settings. The potential importance of FBV was noted previously by Khor and Mayersohn [31, 32] in correcting partition coefficients for residual blood in the tissues. However, few papers exist which cite Khor and Mayersohn and apply the correction to pharmacokinetic data. In order to meaningfully convert between the biophysical and well-stirred partition coefficients using FBV, Fig. 7 Simulated concentration-time curves for the well-stirred tank and flow-limited two-subcompartment model using well-stirred model-optimized and flow-limited two-subcompartment model-calculated partition coefficients for cotinine. Lower FBV tissues (adipose, brain, muscle, splanchnic) and higher FBV tissues (heart, kidney, liver, lung) are simulated (well-stirred tank, solid medium gray lines; flow-limited two-subcompartment, dashed dark gray lines) and plotted against rat pharmacokinetic data from Gabrielsson, et al. [27] (filled dark gray circles, mean; vertical bars, range). The well-stirred model is used to optimize cotinine well-stirred partition coefficients, and cotinine biophysical partition coefficients are calculated from optimized well-stirred partition coefficients based on Eq. 18 (Table 4) . Plasma concentration-time curves are also plotted in each panel (well-stirred, solid light gray lines; flow-limited two-subcompartment, dashed medium gray lines) against rat plasma time course data (filled light gray squares, mean; vertical bars, range). AUC values are reported in Table 5 values for FBV in the literature must be carefully selected. The work of Brown, et al. [17] summarizes tissue FBVs across species and serves as a major reference for permeability-limited modeling. If the flow-limited two-subcompartment model is adopted for use in PBPK, reassessment of available data on FBV, as well as the methods to accurately determine FBV in a range of tissues, may be needed. Experimental techniques used to measure the vascular space require use of a substance impermeant to the endothelium with examples including the work of Everett, et al. [25] using erythrocytes tagged with iron-59 and the recent work of Boswell et al. labeling erythrocytes with technetium-99 in mice [33] . Reconsidering the use and measurement of FBV will also benefit other two-subcompartment models, such as the permeability-limited twosubcompartment intracellular:extracellular model where interstitial fluid volume is required in addition to vascular volume [34, 35] .
Summary and implications for PBPK modeling research
The development of the flow-limited two-subcompartment model has highlighted the need to clearly distinguish between two partition coefficients for use in PBPK tissue models: (1) a partition coefficient (k biophys ) for tissue:plasma drug partitioning arrived at using in vitro approaches and prediction algorithms or analyzing experimental data with a two-subcompartment model; and (2) a well-stirred partition coefficient (k well-stirred ) for use in analyzing experimental data with the well-stirred tank model. The flow-limited two-subcompartment model shows how the partition coefficients can be interconverted to allow agreement of two-subcompartment and well-stirred tank model simulations. When using in vitro or a priori predicted tissue:plasma partition coefficients with the wellstirred tank model, the partition coefficient (k biophys ) should be converted to k well-stirred . Though plasma kinetics do not appear to be substantially impacted by choice of partition coefficient for use in the well-stirred tank, simulation of target tissue drug concentration needed for carrying out mechanistic pharmacodynamic and toxicodynamic modeling may be significantly impacted. A potential advantage to implementing a flow-limited two-subcompartment model is that c 2 can be estimated, with the potential to influence pharmacokinetic-pharmacodynamic modeling.
The work presented herein clarifies previous findings from Thompson and Beard regarding the well-stirred tank model [2, 16] : the well-stirred tank and the flow-limited two-subcompartment model are both appropriate flowlimited PBPK tissue models as long as the correct partition coefficient is used. The development of the flow-limited two-subcompartment model also highlights the need to reconsider the importance of physiological parameters, such as tissue FBV, that may improve PBPK model predictability and interpretation of drug pharmacokinetics and pharmacodynamics.
